What amount sold does ORLI Oncology Ventures II SPV, LLC report in Form D filings?

The latest linked filings report $369K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ORLI Oncology Ventures II SPV, LLC's most recent SEC filing?

ORLI Oncology Ventures II SPV, LLC's most recent Form D filing was on 2026-05-15.

How many investors does ORLI Oncology Ventures II SPV, LLC have?

The most recent Form D filing lists 19 investor(s).

ORLI Oncology Ventures II SPV, LLC

CIK: 0002126245·Pooled Investment Fund·Columbus, OH·Limited Liability Company·Founded 2025

Reported Sold

$368,750

Total Filings

Identified Offerings

Last Filed

May 15, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

May 15, 2026Form D — New notice

Reported sold: $368,750 · Target: $368,750

Rule 506(b)·19 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$368,750

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
May 15, 2026	New	$368,750	$368,750	19

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Propel(x) Syndicates LLC - Series 8309

Pooled Investment Fund

Offering target: $185,000

Filed Nov 2, 2026